Quick Links

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 1.5 Contact Hours.


PER Pulse™ Recaps
 for Community Practice Connections™
: 1st Annual European Congress on Immunotherapies in Cancer™ focuses on a series of video interviews with leading experts in immunotherapy for cancer that are featured in an online CME activity currently available at

Acknowledgment of Commercial Support

This activity is supported by educational grants from Incyte and AstraZeneca.

Community Practice Connections™: 1st Annual European Congress on Immunotherapies in Cancer™

Release Date: December 13, 2016
Expiration Date: December 13, 2017
Media: Internet - based


Activity Overview

This activity focuses on immunotherapies in melanoma, non–small cell lung cancer, and gastric cancer; it consists of a series of brief video interviews of leading and short summaries of clinical data related to issues discussed in the interviews. The content and videos are based on presentations given at the 1st Annual European Congress on Immunotherapies in Cancer™, held September 2016 in Barcelona, Spain. The program is designed for community oncologists and addresses currents standards of care and emerging concepts in cancer immunotherapy.

CME/CE Activity Table of Contents

  • Resistance to Immunotherapy: Mechanisms and Clinical Approaches
    Antoni Ribas, MD, PhD
  • Advanced Lung Cancer: Assessing Single Agents and Combinations in Multiple Lines of Care
    Roman Perez-Soler, MD
  • On the Frontier: Immunotherapy for Gastric Cancers
    Josep Tabernero, MD, PhD
  • Module III: Emerging Strategies
    Faculty Panel 
  • Key Takeaways
  • Survey
  • Posttest

Requirements for Successful Completion

In order to receive a CME/CE certificate, participants must view any number of the modules, complete the posttest with a passing score of 70% or higher, complete the evaluation, and request credit. Participants may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational activity is directed toward medical oncologists and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians' assistants, etc.). Participants will primarily be those whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on immunotherapies and their evolving roles in the treatment of cancer.

Learning Objectives

At the conclusion of this activity, participants should be better prepared to:

  1. Explain mechanistic approaches toward targeting the immune system to treat cancer
  2. Evaluate the clinical applicability of data from clinical trials of immunotherapy strategies
  3. Discuss methods to individualize the use of immunotherapy strategies, including the use of biomarkers
  4. Identify unmet clinical needs in cancer treatment and highly anticipated clinical trials evaluating novel immunotherapeutic approaches

Faculty, Staff, and Planners' Disclosures


Roman Perez-Soler, MD
Chairman, Department of Oncology
Montefiore Medical Center
Professor of Medicine and Molecular Pharmacology
Deputy Cancer Center Director
Albert Einstein College of Medicine
Bronx, New York, USA
Disclosure: Grant/Research Support: National Cancer Institute; Consultant: AstraZeneca, Clovis, Roche/Genentech, Boehringer Ingelheim, Eli Lilly, Adgero; Shareholder: Adgero.


Antoni Ribas, MD, PhD
Professor of Medicine
Professor of Surgery
Professor of Molecular & Medical Pharmacology
David Geffen School of Medicine
Director, Tumor Immunology Program, Jonsson Comprehensive Cancer Center
University of California, Los Angeles
Los Angeles, California, USA
Disclosure: Consultant: Merck Sharp & Dohme, Novartis, Roche; Shareholder: Abraxis, CytomX, Compugen, Five Prime, Kite Pharma.


Josep Tabernero, MD, PhD
Head, Medical Oncology Department
Vall d' Hebron University Hospital
Vall d'Hebron Institute of Oncology (V.H.I.O.)
Barcelona, Spain
Disclosure: Consultant: Amgen, Bayer, Boehringer Ingelheim, Celgene, Chugai, Lilly, Merck Sharp & Dohme, Merck Serono, Novartis, Roche, Sanofi, Symphogen, Takeda, and Taiho.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of Physicians’ Education Resource®, LLC (PER®), to ensure fair balance, independence, objectivity, and scientific rigor in all of our CME/CE activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as a part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.

Staff and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical education purposes only, and is not meant to substitute for the independent medical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of Physicians’ Education Resource®, LLC, or any of the companies that provided commercial support for this activity.

CME Provider Contact Information

Physicians’ Education Resource®, LLC
666 Plainsboro Road, Suite 356
Plainsboro, NJ 08536
Toll Free: 888-949-0045
Local: 609-378-3701
Fax: 609-257-0705

Hardware And Software Requirements 

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)

  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Minimum System Requirements (Mac OS)

  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Become a Member

Forgot Password?
Calendar of Events
Filter By